Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications

COVID-19 complications still present a huge burden on healthcare systems and warrant predictive risk models to triage patients and inform early intervention. Here, we profile 893 plasma proteins from 50 severe and 50 mild-moderate COVID-19 patients, and 50 healthy controls, and show that 375 protein...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Nesf, Maryam A. Y., Abdesselem, Houari B., Bensmail, Ilham, Ibrahim, Shahd, Saeed, Walaa A. H., Mohammed, Sara S. I., Razok, Almurtada, Alhussain, Hashim, Aly, Reham M. A., Al Maslamani, Muna, Ouararhni, Khalid, Khatib, Mohamad Y., Hssain, Ali Ait, Omrani, Ali S., Al-Kaabi, Saad, Al Khal, Abdullatif, Al-Thani, Asmaa A., Samsam, Waseem, Farooq, Abdulaziz, Al-Suwaidi, Jassim, Al-Maadheed, Mohammed, Al-Siddiqi, Heba H., Butler, Alexandra E., Decock, Julie V., Mohamed-Ali, Vidya, Al-Ejeh, Fares
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854716/
https://www.ncbi.nlm.nih.gov/pubmed/35177642
http://dx.doi.org/10.1038/s41467-022-28639-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854716/
https://www.ncbi.nlm.nih.gov/pubmed/35177642
http://dx.doi.org/10.1038/s41467-022-28639-4

Ejemplares similares